NOVAFORM PHARMA
Active Risk: not assessedSummary
NOVAFORM PHARMA is less than twelve months old; there is no public track record yet to compute a bankruptcy probability from. The company has been active since 2026 and the Belgian Official Gazette contains no insolvency or warning signals. No annual accounts have been filed with the National Bank.
Acts, filings and financial milestones
2026
15-07
Gazette deed
IncorporationPermanent representatives: Julia PIEKUNKO, Bernard JOLLY and 2 others · Appointments: Nomainvest SA, Vincent STEPHENNE and 7 others · Auditor report38 facts ▸
Gazette deed
Incorporation
Permanent representatives: Julia PIEKUNKO, Bernard JOLLY and 2 others · Appointments: Nomainvest SA, Vincent STEPHENNE and 7 others · Auditor report38 facts ▸
- Other provision, “documents mis à disposition des actionnaires, article 12:80 alinéa 1er, 1°, 3° et 4° du Code des sociétés et des associations” (deed in French)
- Other provision, “rapport de l'organe d'administration sur la scission, article 12:77 du Code des sociétés et des associations” (deed in French)
- Other provision, “rapport du réviseur d’entreprises sur le projet de scission, article 12:78 du Code des sociétés et des associations” (deed in French)
- Auditor report, 25-06-2026
- Permanent representative, Julia PIEKUNKO (représentante de la société scindée partiellement)
- Power of attorney, Julia PIEKUNKO
- Transfer of a branch of activity or universality, “branch of activity, éléments actifs et passifs de la branche d’activités MMCR” (deed in French)
- Other provision, “gages on the transferred business”, 3 (deed in French)
- Demerger, 10-07-2026
- Share issue, 996268, “proportional to shareholders' rights in the equity of the split company” (deed in French)
- Shareholding, 10-07-2026, 63640
- Shareholding, 10-07-2026, 176726
- +26 further facts in this act
Gazette deed
1 of 1 deed read